A new laser system means that patients with benign prostatic hyperplasia can now undergo outpatient surgery.
The new procedure can also be performed by urologists in office practice. "Transurethral laser vaporisation is an option for all patients with benign prostatic hyperplasia (BPH) with obstructive and irritative symptoms which no longer respond to medication," reported Dr. Wilhelm Jungmann from Darmstadt. The indications for the laser procedure are the same as those for transurethral prostate resection.
In patients with no previous history of cardiac or pulmonary disease, the laser surgery can be performed as an in-office procedure with the new LIFE system from Biolitec. The two arguments for the new procedure which Jungmann found especially convincing were the very low rate of postoperative bleeding and the small amount of anaesthetic required. The actual laser procedure takes only 15 to 30 minutes. "In the U.S. this operation is even carried out under local anaesthesia," the urologist reported. The patients return home on the day of the operation. The decision of whether a catheter is necessary is made from case to case.
Medica: Hall 10 / D78